Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Evoke Pharma (EVOK) Assets Average (2020 - 2025)

Historic Assets Average for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to $15.9 million.

  • Evoke Pharma's Assets Average rose 2061.63% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.9 million, marking a year-over-year increase of 2061.63%. This contributed to the annual value of $12.3 million for FY2024, which is 2995.51% up from last year.
  • Latest data reveals that Evoke Pharma reported Assets Average of $15.9 million as of Q3 2025, which was up 2061.63% from $16.2 million recorded in Q2 2025.
  • In the past 5 years, Evoke Pharma's Assets Average registered a high of $18.4 million during Q2 2021, and its lowest value of $7.5 million during Q4 2023.
  • Its 5-year average for Assets Average is $12.8 million, with a median of $12.6 million in 2022.
  • In the last 5 years, Evoke Pharma's Assets Average surged by 18557.44% in 2021 and then plummeted by 4093.3% in 2023.
  • Quarter analysis of 5 years shows Evoke Pharma's Assets Average stood at $11.1 million in 2021, then increased by 13.67% to $12.6 million in 2022, then tumbled by 40.93% to $7.5 million in 2023, then soared by 112.26% to $15.8 million in 2024, then grew by 0.12% to $15.9 million in 2025.
  • Its last three reported values are $15.9 million in Q3 2025, $16.2 million for Q2 2025, and $16.9 million during Q1 2025.